These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 22354308)
1. Emergence of Proteus mirabilis harboring blaKPC-2 and qnrD in a Chinese Hospital. Hu YY; Cai JC; Zhang R; Zhou HW; Sun Q; Chen GX Antimicrob Agents Chemother; 2012 May; 56(5):2278-82. PubMed ID: 22354308 [TBL] [Abstract][Full Text] [Related]
2. Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China. Zhang C; Xu X; Pu S; Huang S; Sun J; Yang S; Zhang L Infect Genet Evol; 2014 Oct; 27():271-6. PubMed ID: 25107431 [TBL] [Abstract][Full Text] [Related]
3. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria. Boudjemaa H; Allem R; Fonkou MDM; Zouagui S; Khennouchi NCEH; Kerkoud M J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091 [TBL] [Abstract][Full Text] [Related]
4. The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China. Zeng L; Zhang J; Li C; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Zhang X Infect Genet Evol; 2020 Aug; 82():104319. PubMed ID: 32278145 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of quinolone resistance determinant qnrA6 among broad- and extended-spectrum beta-lactam-resistant Proteus mirabilis and Morganella morganii clinical isolates with sul1-type class 1 integron association in a Tunisian Hospital. Mahrouki S; Perilli M; Bourouis A; Chihi H; Ferjani M; Ben Moussa M; Amicosante G; Belhadj O Scand J Infect Dis; 2013 Aug; 45(8):600-5. PubMed ID: 23746343 [TBL] [Abstract][Full Text] [Related]
6. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Cai JC; Zhou HW; Zhang R; Chen GX Antimicrob Agents Chemother; 2008 Jun; 52(6):2014-8. PubMed ID: 18332176 [TBL] [Abstract][Full Text] [Related]
7. Description and plasmid characterization of the qnrD determinant in Proteeae in Wenzhou, Southern China. Chen L; Zhang Y; Du J; Zhang X; Li M; Chen H; Yu X; Sun Y; Zhou T J Microbiol Immunol Infect; 2018 Feb; 51(1):115-122. PubMed ID: 27049282 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital. Crémet L; Caroff N; Dauvergne S; Reynaud A; Lepelletier D; Corvec S Pathol Biol (Paris); 2011 Jun; 59(3):151-6. PubMed ID: 19481883 [TBL] [Abstract][Full Text] [Related]
9. Genotypic characterization of a Proteus mirabilis strain harboring bla Sun L; He J; Shi X; Hu L; Yin Y; Yu Y; Hua X J Infect Public Health; 2023 Jul; 16(7):1033-1036. PubMed ID: 37182289 [TBL] [Abstract][Full Text] [Related]
10. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia. Bedenić B; Firis N; Elveđi-Gašparović V; Krilanović M; Matanović K; Štimac I; Luxner J; Vraneš J; Meštrović T; Zarfel G; Grisold A Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339 [TBL] [Abstract][Full Text] [Related]
11. Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital. Protonotariou E; Poulou A; Politi L; Meletis G; Chatzopoulou F; Malousi A; Metallidis S; Tsakris A; Skoura L Int J Antimicrob Agents; 2020 Aug; 56(2):106060. PubMed ID: 32574790 [TBL] [Abstract][Full Text] [Related]
12. Emergence of extensive drug resistance and high prevalence of multidrug resistance among clinical Proteus mirabilis isolates in Egypt. ElTaweel M; Said HS; Barwa R Ann Clin Microbiol Antimicrob; 2024 May; 23(1):46. PubMed ID: 38790053 [TBL] [Abstract][Full Text] [Related]
14. Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene. Vourli S; Tsorlini H; Katsifa H; Polemis M; Tzouvelekis LS; Kontodimou A; Vatopoulos AC Clin Microbiol Infect; 2006 Jul; 12(7):691-4. PubMed ID: 16774572 [TBL] [Abstract][Full Text] [Related]
15. New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Wang M; Guo Q; Xu X; Wang X; Ye X; Wu S; Hooper DC; Wang M Antimicrob Agents Chemother; 2009 May; 53(5):1892-7. PubMed ID: 19258263 [TBL] [Abstract][Full Text] [Related]
16. Outbreak of KPC-2-Producing Su S; Li C; Zhao Y; Yu L; Wang Y; Wang Y; Bao M; Fu Y; Zhang J; Zhang X Microb Drug Resist; 2020 Sep; 26(9):1009-1018. PubMed ID: 32150494 [No Abstract] [Full Text] [Related]
17. Molecular epidemiology of ciprofloxacin-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Taiwan. Lin CJ; Siu LK; Ma L; Chang YT; Lu PL Microb Drug Resist; 2012 Feb; 18(1):52-8. PubMed ID: 22022870 [TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of antimicrobial susceptibility of Salmonella isolates: First identification of a plasmid carrying qnrD or oqxAB in Taiwan. Kao CY; Chen CA; Liu YF; Wu HM; Chiou CS; Yan JJ; Wu JJ J Microbiol Immunol Infect; 2017 Apr; 50(2):214-223. PubMed ID: 26055690 [TBL] [Abstract][Full Text] [Related]
19. High Prevalence of Plasmid-Mediated Quinolone Resistance Determinants in Escherichia coli and Klebsiella pneumoniae Isolates from Pediatric Patients in China. Xue G; Li J; Feng Y; Xu W; Li S; Yan C; Zhao H; Sun H Microb Drug Resist; 2017 Jan; 23(1):107-114. PubMed ID: 27167505 [TBL] [Abstract][Full Text] [Related]
20. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital. Kim JY; Park YJ; Kim SI; Kang MW; Lee SO; Lee KY J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]